Patients Without Targetable Driver Mutations
1 clinical trials · Condition
◉ Watch Patients Without Targetable Driver Mutations
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of High-Dose Rate Brachytherapy With Immunotherapy and Chemotherapy as Second-Line Treatment for Advanced Non-Small Cell Lung Cancer (NCT06518018) | The First People's Hospital of Neijiang | 2023-09-01 |
Track Patients Without Targetable Driver Mutations automatically
Every clearance here is in the API, with alerts when new ones post.